Cargando…

Oral atenolol therapy for proliferating infantile hemangioma: A prospective study

Propranolol, a lipophilic nonselective β-blocker, has recently been reported to be the treatment of choice for select types of infantile hemangiomas (IHs). Atenolol is a hydrophilic, selective β(1)-blocker and therefore may be not associated with side effects attributable to β(2)-adrenergic receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Yi, Wang, Qi, Chen, Siyuan, Xiang, Bo, Xu, Zhicheng, Li, Yuan, Zhong, Lin, Jiang, Xiaoping, Yang, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998480/
https://www.ncbi.nlm.nih.gov/pubmed/27310994
http://dx.doi.org/10.1097/MD.0000000000003908